166 related articles for article (PubMed ID: 30987997)
1. Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP.
Jiang S; Wang X; Song D; Liu X; Gu Y; Xu Z; Wang X; Zhang X; Ye Q; Tong Z; Yan B; Yu J; Chen Y; Sun M; Wang Y; Gao S
Cancer Res; 2019 Jun; 79(12):3063-3075. PubMed ID: 30987997
[TBL] [Abstract][Full Text] [Related]
2. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.
Wang Z; Hulsurkar M; Zhuo L; Xu J; Yang H; Naderinezhad S; Wang L; Zhang G; Ai N; Li L; Chang JT; Zhang S; Fazli L; Creighton CJ; Bai F; Ittmann MM; Gleave ME; Li W
Neoplasia; 2021 Nov; 23(11):1147-1165. PubMed ID: 34706306
[TBL] [Abstract][Full Text] [Related]
3. IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.
Lo UG; Pong RC; Yang D; Gandee L; Hernandez E; Dang A; Lin CJ; Santoyo J; Ma S; Sonavane R; Huang J; Tseng SF; Moro L; Arbini AA; Kapur P; Raj GV; He D; Lai CH; Lin H; Hsieh JT
Cancer Res; 2019 Mar; 79(6):1098-1112. PubMed ID: 30504123
[TBL] [Abstract][Full Text] [Related]
4. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
5. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
Dambal S; Alfaqih M; Sanders S; Maravilla E; Ramirez-Torres A; Galvan GC; Reis-Sobreiro M; Rotinen M; Driver LM; Behrove MS; Talisman TJ; Yoon J; You S; Turkson J; Chi JT; Freeman MR; Macias E; Freedland SJ
Mol Cancer Res; 2020 May; 18(5):671-684. PubMed ID: 32019810
[TBL] [Abstract][Full Text] [Related]
6. MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways.
Ebron JS; Shankar E; Singh J; Sikand K; Weyman CM; Gupta S; Lindner DJ; Liu X; Campbell MJ; Shukla GC
Cancer Res; 2019 Apr; 79(8):1844-1856. PubMed ID: 30808676
[TBL] [Abstract][Full Text] [Related]
7. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
8. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
Lan X; Lu G; Yuan C; Mao S; Jiang W; Chen Y; Jin X; Xia Q
J Cancer Res Clin Oncol; 2016 Jan; 142(1):177-85. PubMed ID: 26206483
[TBL] [Abstract][Full Text] [Related]
10. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.
Liu CH; Tang WC; Sia P; Huang CC; Yang PM; Wu MH; Lai IL; Lee KH
Int J Med Sci; 2015; 12(1):63-71. PubMed ID: 25552920
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone.
Sawant Dessai A; Dominguez MP; Chen UI; Hasper J; Prechtl C; Yu C; Katsuta E; Dai T; Zhu B; Jung SY; Putluri N; Takabe K; Zhang XH; O'Malley BW; Dasgupta S
Cancer Res; 2021 Jan; 81(1):50-63. PubMed ID: 33115805
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
[TBL] [Abstract][Full Text] [Related]
14. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
Nilchian A; Johansson J; Ghalali A; Asanin ST; Santiago A; Rosencrantz O; Sollerbrant K; Vincent CT; Sund M; Stenius U; Fuxe J
Cancer Res; 2019 Jan; 79(1):47-60. PubMed ID: 30385615
[TBL] [Abstract][Full Text] [Related]
15. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
16. EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways.
Rajput M; Singh R; Singh N; Singh RP
Life Sci; 2021 Dec; 286():120031. PubMed ID: 34627777
[TBL] [Abstract][Full Text] [Related]
17. APMAP Promotes Epithelial-Mesenchymal Transition and Metastasis of Cervical Cancer Cells by Activating the Wnt/β-catenin Pathway.
Zhu X; Xiang Z; Zou L; Chen X; Peng X; Xu D
J Cancer; 2021; 12(20):6265-6273. PubMed ID: 34539899
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
19. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
[TBL] [Abstract][Full Text] [Related]
20. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
